Find Paid Clinical Trials in California

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in California

Top of Directory » All Locations » United States » California




  • Healthy Volunteers
    Lotus Clinical Research is conducting a clinical research study of an investigational medication. You must be between 18 to 55 years old to participate.
  • OTIS Autoimmune Diseases in Pregnancy Project

    Conditions:   Ankylosing Spondylitis;   Psoriatic Arthritis;   Psoriasis;   Rheumatoid Arthritis
    Intervention:  
    Sponsors:   University of California, San Diego;   Organization of Teratology Information Specialists (OTIS);   Amgen
    Recruiting - verified November 2009

  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

    Condition:   Moderate to Severe Postoperative Pain
    Interventions:   Drug: Q8003;   Drug: Morphine sulfate;   Drug: Oxycodone HCl
    Sponsor:   QRxPharma Inc.
    Not yet recruiting - verified November 2009

  • Efficacy of the Aspen Spinous Process System in Anterior Lumbar Interbody Fusion (ALIF)

    Condition:   Degenerative Disc Disease
    Interventions:   Device: Aspen Spinous Process System;   Device: Pedicle Screw Fixation
    Sponsor:   Lanx, Inc.
    Not yet recruiting - verified November 2009

  • Diabetes Support Project: Couples Intervention

    Condition:   Type 2 Diabetes
    Interventions:   Behavioral: Telephone support and behavior change;   Other: Diabetes self-management education
    Sponsor:   State University of New York - Upstate Medical University
    Not yet recruiting - verified November 2009

  • Clinical Evaluation of a Silicone Hydrogel Lens

    Condition:   Lotrafilcon A Contact Lens Use
    Intervention:  
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • A Study With RO4917523 in Patients With Fragile X Syndrome

    Condition:   Fragile X Syndrome
    Interventions:   Drug: RO4917523;   Drug: Placebo;   Drug: RO4917523;   Drug: Placebo
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified November 2009

  • A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions

    Condition:   Basal Cell Carcinoma
    Intervention:  
    Sponsor:   Children's Hospital & Research Center Oakland
    Recruiting - verified November 2009

  • Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear

    Condition:   Corneal Staining
    Interventions:   Device: ReNu Multiplus multipurpose disinfecting solution;   Device: Control
    Sponsor:   Southern California College of Optometry
    Recruiting - verified November 2009

  • A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

    Conditions:   Carcinoma;   Ovarian Cancer;   Ovarian Diseases;   Ovarian Neoplasms
    Interventions:   Biological: AGS-8M4;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: gemcitabine;   Drug: carboplatin
    Sponsors:   Astellas Pharma Inc;   Agensys, Inc.
    Recruiting - verified November 2009

  • Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

    Condition:   Healthy
    Interventions:   Drug: GLYX-13;   Drug: IV normal saline
    Sponsor:   Naurex, Inc
    Recruiting - verified November 2009

  • Cardiac Denervation Surgery for Prevention of Ventricular Tachycardia

    Conditions:   Sudden Cardiac Death;   Ventricular Tachycardia;   Ventricular Fibrillation;   Ischemic Cardiomyopathy
    Interventions:   Procedure: Left cervicothoracic sympathectomy;   Drug: ICD and medical therapy only
    Sponsors:   University of California, Los Angeles;   Divison of Electrophysiology, CARE Hospital in Hyderabad, Andra Pradesh, India;   Department of Cardiology, University of Pavia, Italy;   Arrhythmia Associates, Holy Family Hospital, Mumbai, Maharashtra, India
    Not yet recruiting - verified November 2009

  • Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

    Conditions:   Brain Cancer;   Choroid Plexus Tumors
    Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Cyclophosphamide;   Drug: Dactinomycin;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: Methotrexate;   Drug: Temozolomide;   Drug: Vincristine
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified November 2009

  • A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease

    Condition:   Dry Eye Disease
    Interventions:   Drug: Azithromycin Ophthalmic Solution, 1%;   Drug: Placebo
    Sponsor:   Inspire Pharmaceuticals
    Recruiting - verified November 2009

  • Stage IV Surgery Versus Best Medical Therapy

    Condition:   Stage IV Resectable Melanoma
    Interventions:   Procedure: Surgery;   Procedure: Surgery plus 2 adjuvant doses of BCG;   Other: best medical therapy
    Sponsors:   John Wayne Cancer Institute;   Melanoma Research Alliance
    Recruiting - verified November 2009

  • Developmental and Augmented Intervention for Facilitating Expressive Language

    Conditions:   Joint Engagement;   Enhanced Milieu Training;   Augmentative Communication (AAC)
    Intervention:   Behavioral: JAE Intervention
    Sponsors:   Autism Speaks;   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   Vanderbilt University;   University of California, Los Angeles
    Recruiting - verified November 2009

  • Treating to Target for Patients With Hypertension

    Condition:   Hypertension
    Interventions:   Behavioral: Health coaching;   Behavioral: Health coaching plus home titration
    Sponsors:   University of California, San Francisco;   Kaiser Permanente
    Recruiting - verified November 2009

  • A Phase IIb 78-week Study in Patients on a Basal Insulin +/- Metformin and/or Sulfonylurea and Are Not at Goal to Add BI 10773 vs. Placebo

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: BI 10773
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: MN-221 (Dose Group 1);   Drug: MN-221 (Dose Group 2);   Drug: MN-221 (Dose Group 3)
    Sponsor:   MediciNova
    Recruiting - verified November 2009

  • Study of Peer Relationships at School

    Condition:   Autism
    Intervention:   Behavioral: SKILLS vs ENGAGE
    Sponsors:   Health Resources and Services Administration (HRSA);   Florida State University;   Johns Hopkins University;   University of Michigan;   University of Washington
    Recruiting - verified November 2009

  • Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

    Condition:   Plaque-Type Psoriasis
    Interventions:   Drug: Clobex Spray;   Drug: Vectical Ointment;   Procedure: Excimer Laser
    Sponsor:   University of California, San Francisco
    Not yet recruiting - verified November 2009

  • BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

    Conditions:   Ovarian Neoplasms;   Peritoneal Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Real-Time kV Imaging Versus Real-Time 3D Patient Surface Tracking for Head and Neck Cancer

    Condition:   Head and Neck Cancer
    Interventions:   Procedure: Radiotherapy (Standard of care);   Procedure: 4.1.2 Intrafraction monitoring with EPIC based MV/KV imaging (Standard of care);   Procedure: 4.1.3 Intrafraction monitoring with AlignRT
    Sponsors:   Stanford University;   Varian Medical Systems
    Recruiting - verified November 2009

  • Dose Escalation Study of MLN4924 in Adults With Melanoma

    Condition:   Metastatic Melanoma
    Intervention:   Drug: MLN4924
    Sponsor:   Millennium Pharmaceuticals, Inc.
    Not yet recruiting - verified November 2009

  • Red Cell Mass and Plasma Volume Measurements in Elderly Men and Women With Unexplained Anemia

    Condition:   Anemia
    Intervention:  
    Sponsor:   Stanford University
    Recruiting - verified November 2009

  • A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence

    Condition:   Smoking and Alcohol Dependence
    Interventions:   Drug: varenicline;   Drug: placebo
    Sponsors:   University of California, San Francisco;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified November 2009

  • Varenicline vs Placebo for the Treatment of Methamphetamine Dependence

    Conditions:   Methamphetamine Dependence;   Substance Abuse;   Methamphetamine Abuse
    Interventions:   Drug: Varenicline;   Drug: Placebo
    Sponsors:   National Institute on Drug Abuse (NIDA);   University of California, Los Angeles
    Recruiting - verified November 2009

  • Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer

    Condition:   Locally Advanced Breast Cancer
    Intervention:   Drug: VPA FEC100
    Sponsors:   University of California, San Francisco;   H. Lee Moffitt Cancer Center and Research Institute
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Condition:   Pulmonary Disease, Chronic Obstructive
    Interventions:   Drug: GW642444 Inhalation Powder;   Drug: FF/GW642444 Inhalation Powder
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009

  • Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer

    Condition:   Liver Cancer
    Interventions:   Biological: cixutumumab;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
    Sponsors:   California Cancer Consortium;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • The Dynamics of Human Atrial Fibrillation

    Conditions:   Atrial Fibrillation;   Atrial Tachyarrhythmia
    Intervention:  
    Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified November 2009

  • Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life

    Conditions:   Nightmares;   Insomnia;   Posttraumatic Stress Disorder
    Interventions:   Behavioral: PTSD + IRT/CBT-I;   Behavioral: PTSD + Supportive Care Therapy
    Sponsors:   University of California, San Diego;   National Institutes of Health (NIH);   National Institute of Nursing Research (NINR)
    Not yet recruiting - verified November 2009

  • Study of Blood and Cheek Cell Samples From Patients With Glioma

    Condition:   Brain and Central Nervous System Tumors
    Interventions:   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
    Sponsors:   UCSF Helen Diller Family Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study Evaluating the Efficacy and Safety of SBI-087 in Seropositive Subjects With Active Rheumatoid Arthritis

    Condition:   Active Rheumatoid Arthritis
    Intervention:   Drug: SBI-087
    Sponsor:   Wyeth
    Recruiting - verified November 2009

  • Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients

    Condition:   Prostate Cancer
    Intervention:   Other: SPECT-CT imaging
    Sponsor:   University of California, San Francisco
    Recruiting - verified November 2009

  • Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

    Condition:   Glioblastoma
    Intervention:   Procedure: Gamma Knife Radiosurgery
    Sponsor:   University of California, San Francisco
    Not yet recruiting - verified November 2009

  • A Comparison of the Studer Pouch Versus the T-Pouch Orthotopic Neobladder Urinary Diversion in Bladder Cancer Patients

    Condition:   Bladder Cancer
    Interventions:   Procedure: Studer Pouch orthotopic urinary diversion;   Procedure: T-Pouch orthotopic urinary diversion
    Sponsor:   USC/Norris Comprehensive Cancer Center
    Recruiting - verified November 2009

  • Efficacy and Safety of Budesonide Foam for Patients With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

    Conditions:   Proctitis;   Proctosigmoiditis
    Interventions:   Drug: Budesonide;   Drug: Placebo
    Sponsor:   Salix Pharmaceuticals
    Not yet recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

    Condition:   COPD
    Intervention:   Drug: R7103
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Dose-dependent Effects of Second-hand Smoke on Vascular Function

    Condition:   Cardiovascular Disease
    Intervention:   Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
    Sponsor:   University of California, San Francisco
    Recruiting - verified November 2009

  • Bilateral Oophorectomy Versus Ovarian Conservation

    Conditions:   Oophorectomy;   Hysterectomy
    Interventions:   Procedure: Bilateral salpingo-oophorectomy;   Procedure: Ovarian conservation
    Sponsors:   University of California, San Francisco;   University of Alabama at Birmingham
    Recruiting - verified November 2009

  • A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients

    Condition:   Parkinson's Disease
    Interventions:   Drug: Rasagiline;   Drug: Placebo
    Sponsors:   The Parkinson's Institute;   Teva Neuroscience, Inc.
    Recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment

    Conditions:   Traumatic Brain Injury;   Posttraumatic Stress Disorders;   Trauma;   Combat Disorders;   Pain
    Intervention:   Device: TMRDU
    Sponsors:   University of Illinois;   Department of Defense Telemedicine and Advanced Technology Research Center
    Not yet recruiting - verified November 2009

  • Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine

    Condition:   Multiple Myeloma
    Intervention:   Procedure: kyphoplasty
    Sponsors:   University of California, San Francisco;   Medtronics, Inc.
    Not yet recruiting - verified October 2009

  • Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

    Condition:   Hepatocellular Carcinoma
    Intervention:   Drug: sorafenib with temsirolimus
    Sponsors:   University of California, San Francisco;   Northwestern University
    Not yet recruiting - verified November 2009

  • Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: Southern blotting;   Genetic: cytogenetic analysis;   Genetic: polymerase chain reaction
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials